LINGCORE SCI
LINGCORE SCI
Analyze papers, build evidence-aware reviews, and identify suitable journals with structured AI-assisted workflows designed for clinical and biomedical research.
Turn a DOI, PMID, abstract, or paper into a structured review of study design, PICO, methods, bias, and clinical interpretation.
Try Paper Analyzer →Organize verified sources into an evidence-aware review workflow with clear claims, comparisons, and citation boundaries.
Build a Review →Compare candidate journals by scope, study design, manuscript type, reporting expectations, and submission fit.
Match a Journal →Connect important claims to identifiable sources and make evidence boundaries visible.
Keep study design, estimands, bias, reporting, and clinical interpretation in view.
AI assists the workflow; researchers verify evidence and own the final decision.
Start with a DOI, PMID, abstract, or manuscript and turn the paper into a structured evidence brief.
Organize verified sources into thematic clusters, comparisons, and a traceable review structure.
Compare journals against your manuscript profile, study design, article type, and evidence fit.
A connected guide to causal methods, sequential decisions, and evidence generation for medical researchers.
Learn how to assess bias, limits of agreement, repeatability, proportional bias, and clinical acceptability when comparing measurement methods.
Read Article →
Learn how to define horizon-specific discrimination, handle censoring and competing risks, and report dynamic AUC with calibration and validation.
Read Article →
Learn how repeated randomization estimates proximal effects, time-varying moderation, and intervention performance at eligible decision points.
Read Article →
Learn how trajectory models describe longitudinal heterogeneity, choose between GBTM and GMM, and report probabilistic class membership responsibly.
Read Article →
Learn how latent principal strata address intercurrent events, noncompliance, truncation by death, and assumption-dependent causal effects.
Read Article →
Learn how spline-based survival models estimate absolute risk, time-varying effects, competing events, and extrapolation uncertainty.
Read Article →
Learn how BART models nonlinear relationships, posterior uncertainty, clinical risk, and treatment-effect heterogeneity.
Read Article →
Learn how to distinguish structural zeros, sampling zeros, overdispersion, and two-part clinical count processes.
Read Article →
Learn how Brier score, calibration, discrimination, censoring-aware error, and prediction-error curves should be interpreted in clinical models.
Read Article →
Learn how conditioning on healthcare utilization, complete records, or other common effects can open non-causal pathways in observational studies.
Read Article →
Learn how pseudo-observations support direct regression of survival probability, RMST, cumulative incidence, and multi-state probabilities under censoring.
Read Article →
Learn how joint frailty models connect repeated clinical events with death or discharge, address informative termination, and report component-specific effects.
Read Article →
Learn how quantitative bias analysis examines unmeasured confounding, misclassification, selection bias, E-values, and probabilistic sensitivity analyses.
Read Article →
Learn how overlap weighting emphasizes patients for whom either treatment was plausible, reduces extreme propensity-score influence, and changes the target population.
Read Article →
Learn how augmented inverse probability weighting combines treatment and outcome models, checks positivity, and reports causal effects honestly.
Read Article →
Learn how cumulative-logit models preserve ordered clinical outcomes, when proportional odds is defensible, and how to report category probabilities.
Read Article →
Learn how hierarchical pairwise comparisons prioritize clinically important outcomes and why win difference, component drivers, and absolute measures matter.
Read Article →
Learn how BMA combines plausible models to reduce overconfident variable-selection claims while preserving priors, diagnostics, calibration, and validation.
Read Article →
Learn how causal forests estimate conditional treatment effects and why honesty, calibration, regression comparison, and external validation remain essential.
Read Article →
Learn when Firth logistic regression helps with sparse binary outcomes and separation, and why calibration, validation, and researcher judgment still matter.
Read Article →
Learn how ITS estimates level and slope changes while addressing autocorrelation, seasonality, concurrent events, controlled designs, and reporting boundaries.
Read Article →
Learn how TMLE links estimands, outcome and treatment models, machine learning, cross-fitting, positivity diagnostics, uncertainty, and sensitivity analysis.
Read Article →
Learn how GAMs model nonlinear clinical associations with smooth functions, effective degrees of freedom, uncertainty bands, diagnostics, and validated interpretation.
Read Article →
Learn how measurement error affects exposures, outcomes, biomarkers, and prediction models, and how validation, calibration, SIMEX, and sensitivity analysis address it.
Read Article →
Learn how joint models connect repeated biomarker trajectories with event risk through shared latent structure, informative dropout handling, and dynamic validation.
Read Article →
Learn how landmark analysis defines future-risk populations, uses time-varying clinical information, avoids temporal leakage, and validates dynamic predictions.
Read Article →
Learn how to model overdispersed clinical counts, use exposure-time offsets, assess excess zeros and clustering, and interpret incidence rate ratios responsibly.
Read Article →
Learn how restricted cubic splines preserve continuous information, model nonlinear clinical associations, test curvature, and support interpretable, validated risk curves.
Read Article →
Learn how research skills support literature searching, paper appraisal, statistical planning, evidence-driven writing, citation mapping, and manuscript quality control without replacing researcher judgment.
Read Article →
Learn how intracluster correlation, design effects, cluster-size variation, and cluster-aware models shape power and valid inference in cluster-randomized trials.
Read Article →
Learn when and how to adjust for baseline covariates in randomized trials, from ANCOVA to principled estimators, conditional versus marginal effects, and regulatory reporting.
Read Article →
Learn how multivariate meta-analysis jointly models correlated outcomes, borrows strength across endpoints, handles missing outcomes, and supports valid joint inference.
Read Article →
Learn how to detect, quantify, and adjust for publication bias using funnel plots, small-study-effect tests, trim-and-fill, selection models, and GRADE-based reporting.
Read Article →
Learn how TSA applies sequential monitoring boundaries to cumulative meta-analysis, estimates required information size, and provides adjusted confidence intervals.
Read Article →
Learn how to jointly model sensitivity and specificity, handle threshold effects, assess heterogeneity, and report QUADAS-2 and PRISMA-DTA results.
Read Article →
Learn how treatment policy, hypothetical, composite, principal-stratum, and while-on-treatment strategies answer different real-world clinical questions.
Read Article →
Learn how partial pooling estimates center-specific effects, stabilizes sparse subgroups, and quantifies heterogeneity without hiding uncertainty.
Read Article →
Learn how randomized crossover periods, washout, carryover assessment, and within-person analysis can support rigorous individualized treatment decisions.
Read Article →
Learn how cloning, artificial censoring, and inverse probability of censoring weights emulate treatment-initiation strategies while addressing immortal-time and selection bias.
Read Article →
Randomized trials estimate internally valid effects, but the target-population effect may differ. Learn how to define effect modifiers, assess positivity, and use standardization or sampling weights.
Read Article →
One pooled AUC can conceal clinically important disparities. Learn how to assess subgroup calibration, discrimination, error rates, thresholds, and net benefit.
Read Article →
Test model generalizability across hospitals, studies, regions, or time periods by leaving one meaningful cluster out at a time and quantifying heterogeneity.
Read Article →
External validation shows where a model fails; updating determines how to repair it. Learn when to use recalibration, revision, predictor extension, shrinkage, and independent validation.
Read Article →
A model that performs well in development data is not automatically transportable. Learn how to assess discrimination, calibration, clinical utility, recalibration, and external validity.
Read Article →
Missing data analysis starts with the estimand. Learn MCAR, MAR, MNAR, multiple imputation, pattern-mixture models, delta adjustment, and sensitivity analysis for regulatory-grade trials.
Read Article →Start with one paper free, build your evidence workflow, or request a structured review before submission.